Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
In: Breast Cancer Research and Treatment, Jg. 150 (2015-04-01), Heft 2, S. 279-288
Online
academicJournal
Zugriff:
Titel: |
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
|
---|---|
Autor/in / Beteiligte Person: | Erber, Ramona ; Gluz, Oleg ; Brünner, Nils ; Kreipe, Hans Heinrich ; Pelz, Enrico ; Kates, Ronald ; Bartels, Annette ; Huober, Jens ; Mohrmann, Svjetlana ; Moustafa, Zehra ; Liedtke, Cornelia ; Mobus, Volker ; Augustin, Doris ; Thomssen, Christoph ; Jänicke, Fritz ; Kiechle, Marion ; Kuhn, Walther ; Nitz, Ulrike ; Harbeck, Nadia ; Hartmann, Arndt |
Link: | |
Zeitschrift: | Breast Cancer Research and Treatment, Jg. 150 (2015-04-01), Heft 2, S. 279-288 |
Veröffentlichung: | 2015 |
Medientyp: | academicJournal |
ISSN: | 0167-6806 (print) |
DOI: | 10.1007/s10549-015-3310-x |
Sonstiges: |
|